Localized reentry within the left atrial appendage: arrhythmogenic role in patients undergoing ablation of persistent atrial fibrillation

Left atrial appendage (LAA) is implicated in maintenance of atrial fibrillation (AF) and atrial tachycardia (AT) associated with persistent AF (PsAF) ablation, although little is known about the incidence and mechanism of LAA AT. The purpose of this study was to characterize LAA ATs associated with...

Full description

Saved in:
Bibliographic Details
Published in:Heart rhythm Vol. 8; no. 12; p. 1853
Main Authors: Hocini, Mélèze, Shah, Ashok J, Nault, Isabelle, Sanders, Prashanthan, Wright, Matthew, Narayan, Sanjiv M, Takahashi, Yoshihide, Jaïs, Pierre, Matsuo, Seiichiro, Knecht, Sébastien, Sacher, Frédéric, Lim, Kang-Teng, Clémenty, Jacques, Haïssaguerre, Michel
Format: Journal Article
Language:English
Published: United States 01.12.2011
Subjects:
ISSN:1556-3871, 1556-3871
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Left atrial appendage (LAA) is implicated in maintenance of atrial fibrillation (AF) and atrial tachycardia (AT) associated with persistent AF (PsAF) ablation, although little is known about the incidence and mechanism of LAA AT. The purpose of this study was to characterize LAA ATs associated with PsAF ablation. In 74 consecutive patients undergoing stepwise PsAF ablation, 142 ATs were encountered during index and repeat procedures. Out of 78 focal-source ATs diagnosed by activation and entrainment mapping, 15 (19%) arose from the base of LAA. Using a 20-pole catheter, high-density maps were constructed (n = 10; age 57 ± 6 years) to characterize the mechanism of LAA-AT. The LAA orifice was divided into the posterior ridge and anterior-superior and inferior segments to characterize the location of AT. Fifteen patients with LAA AT had symptomatic PsAF for 17 ± 15 months before ablation. LAA AT (cycle length [CL] 283 ± 30 ms) occurred during the index procedure in four and after 9 ± 7 months in 11 patients. We could map 89% ± 8% AT CLs locally with favorable entrainment from within the LAA, which is suggestive of localized reentry with centrifugal atrial activation. ATs were localized to inferior segment (n = 4), anterior-superior segment (n = 5), and posterior ridge (n = 6) with 1:1 conduction to the atria. Ablation targeting long fractionated or mid-diastolic electrogram within the LAA resulted in tachycardia termination. Postablation, selective contrast radiography demonstrated atrial synchronous LAA contraction in all but one patient. At 18 ± 7 months, 13/15 (87%) patients remained in sinus rhythm without antiarrhythmic drugs. LAA is an important source of localized reentrant AT in patients with PsAF at index and repeat ablation procedures. Ablation targeting the site with long fractionated or mid-diastolic LAA electrogram is highly effective in acute and medium-term elimination of the arrhythmia.
AbstractList Left atrial appendage (LAA) is implicated in maintenance of atrial fibrillation (AF) and atrial tachycardia (AT) associated with persistent AF (PsAF) ablation, although little is known about the incidence and mechanism of LAA AT. The purpose of this study was to characterize LAA ATs associated with PsAF ablation. In 74 consecutive patients undergoing stepwise PsAF ablation, 142 ATs were encountered during index and repeat procedures. Out of 78 focal-source ATs diagnosed by activation and entrainment mapping, 15 (19%) arose from the base of LAA. Using a 20-pole catheter, high-density maps were constructed (n = 10; age 57 ± 6 years) to characterize the mechanism of LAA-AT. The LAA orifice was divided into the posterior ridge and anterior-superior and inferior segments to characterize the location of AT. Fifteen patients with LAA AT had symptomatic PsAF for 17 ± 15 months before ablation. LAA AT (cycle length [CL] 283 ± 30 ms) occurred during the index procedure in four and after 9 ± 7 months in 11 patients. We could map 89% ± 8% AT CLs locally with favorable entrainment from within the LAA, which is suggestive of localized reentry with centrifugal atrial activation. ATs were localized to inferior segment (n = 4), anterior-superior segment (n = 5), and posterior ridge (n = 6) with 1:1 conduction to the atria. Ablation targeting long fractionated or mid-diastolic electrogram within the LAA resulted in tachycardia termination. Postablation, selective contrast radiography demonstrated atrial synchronous LAA contraction in all but one patient. At 18 ± 7 months, 13/15 (87%) patients remained in sinus rhythm without antiarrhythmic drugs. LAA is an important source of localized reentrant AT in patients with PsAF at index and repeat ablation procedures. Ablation targeting the site with long fractionated or mid-diastolic LAA electrogram is highly effective in acute and medium-term elimination of the arrhythmia.
Left atrial appendage (LAA) is implicated in maintenance of atrial fibrillation (AF) and atrial tachycardia (AT) associated with persistent AF (PsAF) ablation, although little is known about the incidence and mechanism of LAA AT.BACKGROUNDLeft atrial appendage (LAA) is implicated in maintenance of atrial fibrillation (AF) and atrial tachycardia (AT) associated with persistent AF (PsAF) ablation, although little is known about the incidence and mechanism of LAA AT.The purpose of this study was to characterize LAA ATs associated with PsAF ablation.OBJECTIVEThe purpose of this study was to characterize LAA ATs associated with PsAF ablation.In 74 consecutive patients undergoing stepwise PsAF ablation, 142 ATs were encountered during index and repeat procedures. Out of 78 focal-source ATs diagnosed by activation and entrainment mapping, 15 (19%) arose from the base of LAA. Using a 20-pole catheter, high-density maps were constructed (n = 10; age 57 ± 6 years) to characterize the mechanism of LAA-AT. The LAA orifice was divided into the posterior ridge and anterior-superior and inferior segments to characterize the location of AT.METHODSIn 74 consecutive patients undergoing stepwise PsAF ablation, 142 ATs were encountered during index and repeat procedures. Out of 78 focal-source ATs diagnosed by activation and entrainment mapping, 15 (19%) arose from the base of LAA. Using a 20-pole catheter, high-density maps were constructed (n = 10; age 57 ± 6 years) to characterize the mechanism of LAA-AT. The LAA orifice was divided into the posterior ridge and anterior-superior and inferior segments to characterize the location of AT.Fifteen patients with LAA AT had symptomatic PsAF for 17 ± 15 months before ablation. LAA AT (cycle length [CL] 283 ± 30 ms) occurred during the index procedure in four and after 9 ± 7 months in 11 patients. We could map 89% ± 8% AT CLs locally with favorable entrainment from within the LAA, which is suggestive of localized reentry with centrifugal atrial activation. ATs were localized to inferior segment (n = 4), anterior-superior segment (n = 5), and posterior ridge (n = 6) with 1:1 conduction to the atria. Ablation targeting long fractionated or mid-diastolic electrogram within the LAA resulted in tachycardia termination. Postablation, selective contrast radiography demonstrated atrial synchronous LAA contraction in all but one patient. At 18 ± 7 months, 13/15 (87%) patients remained in sinus rhythm without antiarrhythmic drugs.RESULTSFifteen patients with LAA AT had symptomatic PsAF for 17 ± 15 months before ablation. LAA AT (cycle length [CL] 283 ± 30 ms) occurred during the index procedure in four and after 9 ± 7 months in 11 patients. We could map 89% ± 8% AT CLs locally with favorable entrainment from within the LAA, which is suggestive of localized reentry with centrifugal atrial activation. ATs were localized to inferior segment (n = 4), anterior-superior segment (n = 5), and posterior ridge (n = 6) with 1:1 conduction to the atria. Ablation targeting long fractionated or mid-diastolic electrogram within the LAA resulted in tachycardia termination. Postablation, selective contrast radiography demonstrated atrial synchronous LAA contraction in all but one patient. At 18 ± 7 months, 13/15 (87%) patients remained in sinus rhythm without antiarrhythmic drugs.LAA is an important source of localized reentrant AT in patients with PsAF at index and repeat ablation procedures. Ablation targeting the site with long fractionated or mid-diastolic LAA electrogram is highly effective in acute and medium-term elimination of the arrhythmia.CONCLUSIONLAA is an important source of localized reentrant AT in patients with PsAF at index and repeat ablation procedures. Ablation targeting the site with long fractionated or mid-diastolic LAA electrogram is highly effective in acute and medium-term elimination of the arrhythmia.
Author Shah, Ashok J
Haïssaguerre, Michel
Lim, Kang-Teng
Hocini, Mélèze
Knecht, Sébastien
Nault, Isabelle
Clémenty, Jacques
Sanders, Prashanthan
Wright, Matthew
Jaïs, Pierre
Takahashi, Yoshihide
Narayan, Sanjiv M
Sacher, Frédéric
Matsuo, Seiichiro
Author_xml – sequence: 1
  givenname: Mélèze
  surname: Hocini
  fullname: Hocini, Mélèze
  email: meleze.hocini@chu-bordeaux.fr
  organization: Hôpital Cardiologique du Haut-Lévêque, Bordeaux, France. meleze.hocini@chu-bordeaux.fr
– sequence: 2
  givenname: Ashok J
  surname: Shah
  fullname: Shah, Ashok J
– sequence: 3
  givenname: Isabelle
  surname: Nault
  fullname: Nault, Isabelle
– sequence: 4
  givenname: Prashanthan
  surname: Sanders
  fullname: Sanders, Prashanthan
– sequence: 5
  givenname: Matthew
  surname: Wright
  fullname: Wright, Matthew
– sequence: 6
  givenname: Sanjiv M
  surname: Narayan
  fullname: Narayan, Sanjiv M
– sequence: 7
  givenname: Yoshihide
  surname: Takahashi
  fullname: Takahashi, Yoshihide
– sequence: 8
  givenname: Pierre
  surname: Jaïs
  fullname: Jaïs, Pierre
– sequence: 9
  givenname: Seiichiro
  surname: Matsuo
  fullname: Matsuo, Seiichiro
– sequence: 10
  givenname: Sébastien
  surname: Knecht
  fullname: Knecht, Sébastien
– sequence: 11
  givenname: Frédéric
  surname: Sacher
  fullname: Sacher, Frédéric
– sequence: 12
  givenname: Kang-Teng
  surname: Lim
  fullname: Lim, Kang-Teng
– sequence: 13
  givenname: Jacques
  surname: Clémenty
  fullname: Clémenty, Jacques
– sequence: 14
  givenname: Michel
  surname: Haïssaguerre
  fullname: Haïssaguerre, Michel
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21762673$$D View this record in MEDLINE/PubMed
BookMark eNpNkE1LxDAQhoOsuB_6CwTJzdPWJO2mqTdZ_IIFL3ouaTJps3STmmSR9R_4ry3sCp5mGJ55ZnjnaOK8A4SuKckoofxum3UhdbuMEUozUmaE5mdoRlcrvsxFSSf_-imax7glhFWc5BdoymjJGS_zGfrZeCV7-w0aBwCXwgF_2dRZh1MHuAeTsEzByh7LYQCnZQv3WIbQHcbTvgVnFQ6-BzxuDDLZURHx3mkIrbeuxbLpx6l32Bs8QIg2phH5cxrbBNsfiUt0bmQf4epUF-jj6fF9_bLcvD2_rh82S7USPC1zqasCuCgqoAqIoqYpqtxUhRKEGl5o3WjDNCuMKlUjORFCFkRQRkTOBDFsgW6P3iH4zz3EVO9sVDB-4cDvY12RUUQKWo3kzYncNzvQ9RDsToZD_Zce-wVaO3jO
CitedBy_id crossref_primary_10_1111_pace_12422
crossref_primary_10_1111_jce_15157
crossref_primary_10_1016_j_repce_2017_12_004
crossref_primary_10_1093_europace_eux274
crossref_primary_10_1016_j_jacc_2019_06_045
crossref_primary_10_3390_jcm13030679
crossref_primary_10_1016_j_iccl_2017_12_001
crossref_primary_10_1007_s10840_017_0256_4
crossref_primary_10_1016_j_ccep_2025_02_004
crossref_primary_10_1016_j_hrthm_2014_03_051
crossref_primary_10_1016_j_hrthm_2018_05_020
crossref_primary_10_1016_j_jacc_2014_03_022
crossref_primary_10_1161_CIRCEP_116_004372
crossref_primary_10_1161_CIRCEP_120_008390
crossref_primary_10_1007_s00059_017_4559_0
crossref_primary_10_1016_j_ccep_2020_02_002
crossref_primary_10_1586_14779072_2015_1057123
crossref_primary_10_1007_s10840_014_9902_2
crossref_primary_10_1186_s12872_023_03599_9
crossref_primary_10_1161_HAE_0000000000000078
crossref_primary_10_1016_j_ahj_2015_09_019
crossref_primary_10_1016_j_hrthm_2019_10_020
crossref_primary_10_1016_j_jacc_2016_06_077
crossref_primary_10_1016_j_jacep_2020_01_013
crossref_primary_10_1002_joa3_12095
crossref_primary_10_1161_CIRCEP_120_009409
crossref_primary_10_1080_17434440_2019_1653181
crossref_primary_10_3389_fcvm_2021_782235
crossref_primary_10_3389_fcvm_2020_00043
crossref_primary_10_1161_JAHA_114_001581
crossref_primary_10_1161_CIRCEP_113_000318
crossref_primary_10_1016_j_jaccas_2019_12_032
crossref_primary_10_1016_j_cpcardiol_2015_01_005
crossref_primary_10_1016_j_hrcr_2022_02_012
crossref_primary_10_1007_s11936_018_0620_4
crossref_primary_10_1161_CIR_0000000000000041
crossref_primary_10_3389_fcvm_2022_928384
crossref_primary_10_1007_s10840_015_0012_6
crossref_primary_10_1016_j_hroo_2024_11_018
crossref_primary_10_1016_j_hrthm_2023_12_003
crossref_primary_10_3389_fphar_2020_581837
crossref_primary_10_1007_s10554_021_02169_4
crossref_primary_10_1016_j_jacep_2019_02_009
crossref_primary_10_1097_HCO_0000000000000573
crossref_primary_10_1111_jce_13276
crossref_primary_10_1016_j_ccep_2019_11_004
crossref_primary_10_1016_j_asjsur_2023_08_215
crossref_primary_10_1016_j_hrthm_2021_01_006
crossref_primary_10_1056_NEJMc1508689
crossref_primary_10_1161_CIRCEP_111_968750
crossref_primary_10_1161_CIRCULATIONAHA_118_034187
crossref_primary_10_1016_j_jacep_2016_06_006
crossref_primary_10_1016_j_jacep_2016_08_010
crossref_primary_10_3389_fcvm_2023_1190860
crossref_primary_10_1007_s10840_019_00657_1
crossref_primary_10_3389_fcvm_2021_759563
crossref_primary_10_3389_fcvm_2022_1009494
crossref_primary_10_1016_j_ipej_2022_09_004
crossref_primary_10_1016_j_jacep_2019_08_012
crossref_primary_10_1016_j_joa_2017_07_001
crossref_primary_10_1186_s12872_021_01930_w
crossref_primary_10_1016_j_jtcvs_2013_07_011
crossref_primary_10_1016_j_jacep_2015_04_006
crossref_primary_10_1016_j_crvasa_2017_06_008
crossref_primary_10_1016_j_jacep_2020_09_002
crossref_primary_10_1016_j_repc_2017_09_011
crossref_primary_10_1053_j_jvca_2015_04_025
crossref_primary_10_1136_bmjopen_2024_086485
crossref_primary_10_18501_arrhythmia_2018_012
crossref_primary_10_1007_s10840_016_0174_x
crossref_primary_10_1111_pace_14878
crossref_primary_10_1007_s10840_022_01217_w
crossref_primary_10_1111_jce_15962
crossref_primary_10_1016_j_jacep_2020_06_011
crossref_primary_10_1007_s12181_017_0146_0
crossref_primary_10_1016_j_hrthm_2014_09_053
crossref_primary_10_1155_2021_9999412
crossref_primary_10_1111_jce_14638
crossref_primary_10_1111_jce_13825
crossref_primary_10_1016_j_ccep_2020_01_002
crossref_primary_10_1016_j_jacep_2019_10_007
crossref_primary_10_1111_jce_13148
crossref_primary_10_1016_j_jacep_2017_10_004
crossref_primary_10_1111_jce_12655
crossref_primary_10_1111_jce_15889
crossref_primary_10_1007_s11886_020_01387_x
crossref_primary_10_1016_j_amjcard_2018_03_027
crossref_primary_10_1016_j_jacc_2016_07_770
crossref_primary_10_1016_j_jacep_2017_07_007
crossref_primary_10_1016_j_jacep_2020_07_003
crossref_primary_10_3892_etm_2018_6243
crossref_primary_10_1016_j_trsl_2014_10_007
crossref_primary_10_1016_j_hrthm_2017_05_012
crossref_primary_10_1016_j_hrthm_2014_01_019
ContentType Journal Article
Copyright Copyright © 2011. Published by Elsevier Inc.
Copyright_xml – notice: Copyright © 2011. Published by Elsevier Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.hrthm.2011.07.013
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1556-3871
ExternalDocumentID 21762673
Genre Journal Article
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: K24 HL103800
– fundername: NHLBI NIH HHS
  grantid: R01 HL083359
GroupedDBID ---
--K
.1-
.FO
0R~
1B1
1P~
4.4
457
53G
5GY
5VS
AAEDT
AAEDW
AALRI
AAQFI
AAQQT
AAWTL
AAXUO
ABJNI
ABLJU
ABMAC
ABWVN
ACGFS
ACRPL
ADBBV
ADMUD
ADNMO
AENEX
AEVXI
AFCTW
AFJKZ
AFRHN
AFTJW
AGCQF
AIGII
AITUG
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
BELOY
CGR
CS3
CUY
CVF
DU5
EBS
ECM
EFJIC
EFKBS
EIF
EJD
F5P
FDB
G-Q
GBLVA
HZ~
IHE
J1W
K-O
M41
NPM
NQ-
O9-
OA.
OL~
P2P
RIG
ROL
RPZ
SEL
SES
SEW
XH2
Z5R
7X8
ID FETCH-LOGICAL-c586t-3ad94e6849e1ce0c1fb493f94c801f64ddbdf2d24fc7cba6088a40812083280f2
IEDL.DBID 7X8
ISICitedReferencesCount 92
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000298139600007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1556-3871
IngestDate Sat Sep 27 23:40:35 EDT 2025
Mon Jul 21 06:05:34 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License Copyright © 2011. Published by Elsevier Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c586t-3ad94e6849e1ce0c1fb493f94c801f64ddbdf2d24fc7cba6088a40812083280f2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 21762673
PQID 908010419
PQPubID 23479
ParticipantIDs proquest_miscellaneous_908010419
pubmed_primary_21762673
PublicationCentury 2000
PublicationDate 2011-12-01
PublicationDateYYYYMMDD 2011-12-01
PublicationDate_xml – month: 12
  year: 2011
  text: 2011-12-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Heart rhythm
PublicationTitleAlternate Heart Rhythm
PublicationYear 2011
References 11469446 - J Cardiovasc Electrophysiol. 2001 Jul;12(7):852-66
16643401 - J Cardiovasc Electrophysiol. 2006 Mar;17(3):279-85
10709241 - Pacing Clin Electrophysiol. 2000 Feb;23(2):283-5
16302892 - J Cardiovasc Electrophysiol. 2005 Nov;16(11):1125-37
16949495 - J Am Coll Cardiol. 2006 Sep 5;48(5):1010-7
20129293 - Heart Rhythm. 2010;7(2):173-80
17456134 - J Cardiovasc Electrophysiol. 2007 May;18(5):459-64
17599941 - Europace. 2007 Jun;9(6):335-79
18245120 - Eur Heart J. 2008 Feb;29(3):356-62
20487116 - J Cardiovasc Electrophysiol. 2010 Oct;21(10):1085-93
10869265 - Circulation. 2000 Jun 27;101(25):2928-34
18243812 - Heart Rhythm. 2008 Mar;5(3):475-8
16101637 - J Cardiovasc Electrophysiol. 2005 Aug;16(8):917-9
15184286 - Circulation. 2004 Jun 22;109(24):3007-13
16302893 - J Cardiovasc Electrophysiol. 2005 Nov;16(11):1138-47
16903968 - J Cardiovasc Electrophysiol. 2006 Aug;17(8):895-8
20132379 - J Cardiovasc Electrophysiol. 2010 Aug 1;21(8):933-5
20606120 - Circulation. 2010 Jul 13;122(2):109-18
16344401 - Circulation. 2005 Dec 13;112(24):3688-96
16325047 - J Am Coll Cardiol. 2005 Dec 6;46(11):2088-99
17103313 - J Interv Card Electrophysiol. 2006 Sep;16(3):153-67
16461833 - Circulation. 2006 Feb 7;113(5):616-25
17394963 - J Am Coll Cardiol. 2007 Mar 27;49(12):1306-14
17905333 - Heart Rhythm. 2007 Oct;4(10):1284-91
18452884 - Heart Rhythm. 2008 May;5(5):766-7
17602290 - J Interv Card Electrophysiol. 2007 Jun;19(1):45-8
15520313 - Circulation. 2004 Nov 9;110(19):2996-3002
10571372 - J Cardiovasc Electrophysiol. 1999 Nov;10(11):1525-33
12065320 - Circ Res. 2002 Jun 14;90(11):1173-80
References_xml – reference: 17905333 - Heart Rhythm. 2007 Oct;4(10):1284-91
– reference: 18245120 - Eur Heart J. 2008 Feb;29(3):356-62
– reference: 18243812 - Heart Rhythm. 2008 Mar;5(3):475-8
– reference: 15520313 - Circulation. 2004 Nov 9;110(19):2996-3002
– reference: 20129293 - Heart Rhythm. 2010;7(2):173-80
– reference: 17602290 - J Interv Card Electrophysiol. 2007 Jun;19(1):45-8
– reference: 20487116 - J Cardiovasc Electrophysiol. 2010 Oct;21(10):1085-93
– reference: 16643401 - J Cardiovasc Electrophysiol. 2006 Mar;17(3):279-85
– reference: 16302893 - J Cardiovasc Electrophysiol. 2005 Nov;16(11):1138-47
– reference: 18452884 - Heart Rhythm. 2008 May;5(5):766-7
– reference: 10571372 - J Cardiovasc Electrophysiol. 1999 Nov;10(11):1525-33
– reference: 11469446 - J Cardiovasc Electrophysiol. 2001 Jul;12(7):852-66
– reference: 16949495 - J Am Coll Cardiol. 2006 Sep 5;48(5):1010-7
– reference: 16903968 - J Cardiovasc Electrophysiol. 2006 Aug;17(8):895-8
– reference: 15184286 - Circulation. 2004 Jun 22;109(24):3007-13
– reference: 17599941 - Europace. 2007 Jun;9(6):335-79
– reference: 20606120 - Circulation. 2010 Jul 13;122(2):109-18
– reference: 17394963 - J Am Coll Cardiol. 2007 Mar 27;49(12):1306-14
– reference: 16101637 - J Cardiovasc Electrophysiol. 2005 Aug;16(8):917-9
– reference: 16461833 - Circulation. 2006 Feb 7;113(5):616-25
– reference: 16325047 - J Am Coll Cardiol. 2005 Dec 6;46(11):2088-99
– reference: 17456134 - J Cardiovasc Electrophysiol. 2007 May;18(5):459-64
– reference: 16302892 - J Cardiovasc Electrophysiol. 2005 Nov;16(11):1125-37
– reference: 16344401 - Circulation. 2005 Dec 13;112(24):3688-96
– reference: 20132379 - J Cardiovasc Electrophysiol. 2010 Aug 1;21(8):933-5
– reference: 10709241 - Pacing Clin Electrophysiol. 2000 Feb;23(2):283-5
– reference: 10869265 - Circulation. 2000 Jun 27;101(25):2928-34
– reference: 12065320 - Circ Res. 2002 Jun 14;90(11):1173-80
– reference: 17103313 - J Interv Card Electrophysiol. 2006 Sep;16(3):153-67
SSID ssj0029603
Score 2.3786995
Snippet Left atrial appendage (LAA) is implicated in maintenance of atrial fibrillation (AF) and atrial tachycardia (AT) associated with persistent AF (PsAF) ablation,...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1853
SubjectTerms Atrial Appendage - physiopathology
Atrial Appendage - surgery
Atrial Fibrillation - physiopathology
Atrial Fibrillation - surgery
Catheter Ablation
Electrophysiologic Techniques, Cardiac
Female
Humans
Male
Middle Aged
Treatment Outcome
Title Localized reentry within the left atrial appendage: arrhythmogenic role in patients undergoing ablation of persistent atrial fibrillation
URI https://www.ncbi.nlm.nih.gov/pubmed/21762673
https://www.proquest.com/docview/908010419
Volume 8
WOSCitedRecordID wos000298139600007&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT4QwEG7UNcaL78f6Sg9eq1BKoV6MMW48uJs9aLI3UkrrkqyAgCbrP_BfOwV2b8aDF06U0DLMfJ35Oh9Cl66fUNssm3icx4RxzyWCckkolcw3ge9r0YpNBKNROJmIccfNqTpa5cInNo46yZXNkV8LgDawdXDFbfFOrGiULa52ChqrqOcBkrFGHUyWRQQK4Lzh1_s-ty1k3UXToYbeNS3r6VvXwjO4cqy8wW8Qswk1g-1_vuQO2uowJr5rjWIXrehsD20Muyr6Pvp-sgEs_dIJtqybupxjm45NMwxoEM-0qbFs1DywLKxELricGyzLcjqHyeRgcanClpWIYUTXl7XC9jBa-ZpDJMQybgl2ODe4sPk4sKRs-UxjDxnM2jsO0Mvg4fn-kXSSDET5Ia-JJxPBNA-Z0K7SjnJNzIRnBFMwccNZksSJoQllRgUqlhx8mGSAOiggPRo6hh6itSzP9DHC1IkdZmiomfHBcRipA09TyQEhxmGoVB_hxRpHYPK2jiEznX9U0XKV--io_U5R0bbmiGCDBTu0wDv5e_Ap2mzyww015Qz1DPzu-hytq886rcqLxpTgOhoPfwBF_tZp
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Localized+reentry+within+the+left+atrial+appendage%3A+arrhythmogenic+role+in+patients+undergoing+ablation+of+persistent+atrial+fibrillation&rft.jtitle=Heart+rhythm&rft.au=Hocini%2C+M%C3%A9l%C3%A8ze&rft.au=Shah%2C+Ashok+J&rft.au=Nault%2C+Isabelle&rft.au=Sanders%2C+Prashanthan&rft.date=2011-12-01&rft.issn=1556-3871&rft.eissn=1556-3871&rft.volume=8&rft.issue=12&rft.spage=1853&rft_id=info:doi/10.1016%2Fj.hrthm.2011.07.013&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1556-3871&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1556-3871&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1556-3871&client=summon